Hematology and Oncology

The Hematology/Oncology course will cover a broad range of topics in the disciplines of Hematology and Oncology and instruction will take place over five weeks. Instruction in both Hematology and Oncology will build on information previously introduced in Fundamentals and will allow for further application and advancement of this knowledge. Emphasis within the course will be on correlation of underlying biochemistry, cell biology, physiology, pathophysiology, histology, immunology, and pharmacology with clinical aspects of hematologic and oncologic disorders. The Hematology content of the course will include a comprehensive consideration of the entire spectrum of hematologic disorders. While hematologic disorders may present in isolation, they often have multisystem manifestations. In view of this and given the integrative nature of the CMSRU curriculum, it will not be uncommon for some hematologic conditions discussed within the course to be revisited in subsequent phase 1 courses. The Oncology content of the course will primarily consist of broader overviews of concepts, as most of the teaching of specific neoplastic disorders will be presented in subsequent organ-system courses (e.g. a detailed discussion lung cancer will be covered during the Pulmonary course). Integration with other courses running simultaneously (Foundations of Medical Practice and Scholars’ Workshop) will include consideration of the principles of disease prevention and screening, breaking bad news, and living with chronic debilitating diseases.

Upon completion of this course, students will be able to: